Alzheimer's Drug Discovery Foundation and Harrington Discovery Institute Center for Brain Health Medicines Invite Proposals for 2024 ADDF-Harrington Scholar Award
Comunicato Precedente
Comunicato Successivo
The Request for Proposals (RFP) is open to academic investigators at accredited medical centers, research institutions, and universities in the United States, Canada, and the United Kingdom. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer's field are strongly encouraged to apply.
This award provides a combination of financial support and expert drug development guidance. Award recipients will receive financial support up to $600,000 over two years, dedicated drug development and project management support, and an opportunity to qualify for investment funds.
The 2024 ADDF-Harrington Scholar RFP places high priority on targets related to emerging therapeutic areas for dementia, particularly:
Other novel targets are encouraged. These include, but are not limited to, the following:
Letters of Intent (LOI) must be submitted online here and will be accepted through June 3, 2024 at 5:00 pm EDT. We encourage an interactive application process in efforts to solicit the best applications. Scientific inquiries can be directed to either:
Andrew A. Pieper, MD, PhD
Director, Center for Brain Health Medicines
Harrington Discovery Institute
Andrew.Pieper@HarringtonDiscovery.org
or
Meriel Owen, PhD
Director, Search and Evaluation
Alzheimer's Drug Discovery Foundation
mowen@alzdiscovery.org
View original content:https://www.prnewswire.co.uk/news-releases/alzheimers-drug-discovery-foundation-and-harrington-discovery-institute-center-for-brain-health-medicines-invite-proposals-for-2024-addf-harrington-scholar-award-302104548.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
